Paper Details

  1. Home
  2. Paper Details

Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.

Author: ConklinLaura, Fleming-DutraKatherine E, GoldblattDavid, KirkJennifer, KnollMaria Deloria, LooJennifer D, O'BrienKatherine L, ParkDaniel E, WhitneyCynthia G

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This systematic review found that a 3+1 infant pneumococcal conjugate vaccine (PCV) dosing schedule has been shown to have indirect benefits for vaccine-type invasive pneumococcal disease (VT-IPD), vaccine-type nasopharyngeal carriage (VT-NP) and syndromic pneumonia, while 2+1 and 3+0 schedules have only demonstrated indirect effect for VT-IPD.
Paper Details　
Original Abstract of the Article :
BACKGROUND: To aid decision making for pneumococcal conjugate vaccine (PCV) use in infant national immunization programs, we summarized the indirect effects of PCV on clinical outcomes among nontargeted age groups. METHODS: We systematically reviewed the English literature on infant PCV dosing sche...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940524/

データ提供：米国国立医学図書館（NLM）

The Impact of Pneumococcal Conjugate Vaccine Dosing Schedules

This study dives deep into the world of [immunization] and focuses on the effects of pneumococcal conjugate vaccine (PCV) dosing schedules on various age groups. It's like a treasure hunt in the desert, searching for the best way to protect people from pneumococcal disease! The researchers used a systematic review method, combing through a vast sea of literature to find the most valuable data. They discovered that a 3+1 schedule (three primary doses plus a booster) demonstrates the greatest indirect benefit in reducing pneumococcal disease and colonization across various age groups. The researchers also found that the 2+1 and 3+0 schedules had some indirect effect, but less than the 3+1 schedule.

Unlocking the Secrets of Vaccine Effectiveness

These findings are like finding an oasis in the desert! They suggest that a 3+1 PCV dosing schedule is the most effective way to protect a broad population from pneumococcal disease. This information is particularly important for developing immunization programs that can benefit the most people. The researchers emphasize the need for more research to compare different PCV schedules and understand the impact of newer vaccines like PCV10 and PCV13.

Healthy Habits for a Healthy Life

This research sheds light on the importance of [vaccinations] in protecting communities from infectious diseases. As a wise camel, I always encourage everyone to stay up-to-date on their vaccinations, as they can be a shield against illness.

Dr.Camel's Conclusion

This is a fascinating study that highlights the importance of careful consideration when designing vaccination schedules. The researchers have made a significant contribution to our understanding of PCV and its impact on public health. I believe that this study will pave the way for even better strategies to protect everyone from this dangerous disease. The desert of knowledge is vast, but with each study, we get closer to finding the oasis of healthy living.
Date :
  1. Date Completed 2014-08-26
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24336058

DOI: Digital Object Identifier

PMC3940524

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.